Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Neuro Stents & Coils Technology and Market Forecast
4.
Outsourcing in Drug Discovery, 3rd Edition
5.
American Hospital Register
6.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
7.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Commercial Opportunities for Enzyme Technologies, 3rd Edition
While the bulk of the business for enzymes is still serving the industrial market, the growth areas are increasing utilizing biotechnology. Revolutionary changes in molecular biology are churning out thousands of new uses of enzyme technology, fueling major growth in this multi-billion-dollar field.
D&MD's Commercial Opportunities in Enzyme Technologies, 3rd Edition examines the many current opportunities for enzymes as well as areas targeted for future growth. Specific attention is paid to the growing and various uses of enzymes over several industries from industrial uses to therapeutic targets. In addition, this Report profiles companies designing and producing enzymes, detailing their technologies and product pipelines.
> Detailed discussion of the process of engineering enzymes including lessons learned from protein engineering, helping you avoid common pitfalls.
> Thorough overview of the multiple uses of enzymes proving, the breadth of this technology and uncovering the most lucrative market opportunities
> A market analysis of Enzymes as commercial products, featuring discussions of the expanding fields of therapeutic enzymes, biologicals, and blood derivatives
> Speculation about the future growth opportunities of enzymes, including a full analysis of strategic issues facing the competitors in the Enzyme industry
> A thorough analysis of 50 companies involved with enzyme technologies, including patent summaries, providing a window into the enzyme playing field
Enzymes, the workhorses of various industrial processes, are gaining significant headway in the biotechnology and pharmaceutical industries. Industrial enzyme uses are evolving for the food processing, detergent, animal, feed and fuel alcohol markets. Some new uses include human enzymes as therapeutics, enzyme inhibitors used in therapy, and enzymes used in "green chemistry" and biocatalysis. Enzyme usage has also taken on a new synthetic life, as they are evolved to carry out reactions for which they were never "designed." It is abundantly clear that a bright, and competitive, future is in store for the use of enzymes.
Much progress has been made over the last five years in the engineering of enzymes through various techniques, from evolution to rational design. Learn about the latest enzyme production techniques when you order D&MD's Commercial Opportunities in Enzyme Technology, 3rd Edition.
Nov-06 Pages 302
List of Company Profiles
Price
PDF $4,950.00
Printed $5,150.00
CD-ROM $5,150.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.